Prenatal CBD Prevented Autism-Like Behaviors in a Rat Stress Model

Broad-spectrum CBD oil (10 mg/kg/day, THC-free) administered to pregnant rats during embryonic days 3-16 significantly reduced all three core ASD-related behavioral measures in male offspring from a neuroinflammation-based ASD model: decreased vocalizations when alone (social communication), fewer marbles buried (repetitive behavior), and increased time with a novel peer (social interaction).

Neurodevelopmental rat model of ASD using stress and terbutaline exposure during pre- and postnatal development to induce neuroinflammation. Pregnant dams received daily IP injections of broad-spectrum CBD oil (10 mg/kg, THC-free) or vehicle during embryonic days 3-16. Male offspring were assessed on three behavioral measures corresponding to ASD core symptoms.

ASD diagnosis has increased from 1 in 150 to 1 in 36 US children, and there are no approved prevention strategies. This study suggests prenatal CBD might prevent autism-like behaviors by counteracting neuroinflammation during fetal development, though this is very early-stage evidence.

If neuroinflammation contributes to ASD development, and CBD can safely reduce prenatal neuroinflammation, this could represent a novel prevention approach. However, the gap between animal prevention models and human clinical application is enormous.

Animal model that may not reflect human ASD etiology. Only male offspring tested. The neuroinflammation model (stress + terbutaline) may not represent the most common ASD risk pathways. IP administration does not reflect typical human use. No long-term follow-up of offspring.